Clinical Trial Update: 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea [Phase 4]

View source ↗

Summary

Phase 4 trial update describing a 15-day sequential therapy for Helicobacter pylori infection conducted in Korea; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED